{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:32:44Z","timestamp":1772929964138,"version":"3.50.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,1]]},"DOI":"10.1165\/ajrcmb.25.6.f222","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T21:40:45Z","timestamp":1365025245000},"page":"673-675","source":"Crossref","is-referenced-by-count":6,"title":["A Novel LPS-Inducible CCR3 Activator"],"prefix":"10.1093","volume":"25","author":[{"given":"Craig M.","family":"Lilly","sequence":"first","affiliation":[{"name":"Combined program in Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and Department of Atherosclerosis and Endocrinology, Merck Research Laboratories, Rahway, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce L.","family":"Daugherty","sequence":"additional","affiliation":[{"name":"Combined program in Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and Department of Atherosclerosis and Endocrinology, Merck Research Laboratories, Rahway, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,1]]},"reference":[{"key":"2026030700011353400_B1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/84298","article-title":"Chemokines: immunology's high impact factors.","volume":"2","author":"Mackay","year":"2001","journal-title":"Nat. Immunol."},{"key":"2026030700011353400_B2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines: chemotactic cytokines that mediate inflammation.","volume":"338","author":"Luster","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"2026030700011353400_B3","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.4049\/jimmunol.162.5.2946","article-title":"Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.","volume":"162","author":"Sabroe","year":"1999","journal-title":"J. Immunol."},{"key":"2026030700011353400_B4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1172\/JCI119145","article-title":"Chemokine receptor usage by human eosinophils: the importance of CCR3 demonstrated using an antagonistic monoclonal antibody.","volume":"99","author":"Heath","year":"1997","journal-title":"J. Clin. Invest."},{"key":"2026030700011353400_B5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1165\/ajrcmb.25.6.4401","article-title":"LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and eotaxin.","volume":"25","author":"Penido","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"2026030700011353400_B6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4049\/jimmunol.160.2.624","article-title":"Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus.","volume":"160","author":"Alcami","year":"1998","journal-title":"J. Immunol."},{"key":"2026030700011353400_B7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1359-6101(99)00018-0","article-title":"Evasion and exploitation of chemokines by viruses.","volume":"10","author":"Lalani","year":"1999","journal-title":"Cytokine Growth Factor Rev."},{"key":"2026030700011353400_B8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/84214","article-title":"Viral exploitation and subversion of the immune system through chemokine mimicry.","volume":"2","author":"Murphy","year":"2001","journal-title":"Nat. Immunol."},{"key":"2026030700011353400_B9","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.4049\/jimmunol.165.6.3418","article-title":"Local blockade of allergic airway hyperreactivity and inflammation by the poxvirus-derived pan-CC-chemokine inhibitor vCCI.","volume":"165","author":"Dabbagh","year":"2000","journal-title":"J. Immunol."},{"key":"2026030700011353400_B10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.183.1.195","article-title":"Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.","volume":"183","author":"Foster","year":"1996","journal-title":"J. Exp. Med."},{"key":"2026030700011353400_B11","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1067\/mai.2001.118600","article-title":"IL-13 induces eosinophil recruitment into the lung by an IL-5- andeotaxin-dependent mechanism.","volume":"108","author":"Pope","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026030700011353400_B12","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1084\/jem.183.5.2349","article-title":"Cloning, expression, and characterization of the human eosinophil eotaxin receptor.","volume":"183","author":"Daugherty","year":"1996","journal-title":"J. Exp. Med."},{"key":"2026030700011353400_B13","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1084\/jem.183.6.2437","article-title":"Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.","volume":"183","author":"Ponath","year":"1996","journal-title":"J. Exp. Med."},{"key":"2026030700011353400_B14","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1084\/jem.185.12.2171","article-title":"Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.","volume":"185","author":"Forssmann","year":"1997","journal-title":"J. Exp. Med."},{"key":"2026030700011353400_B15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jlb.62.5.667","article-title":"Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.","volume":"62","author":"White","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"2026030700011353400_B16","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2152::AID-IMMU2152>3.0.CO;2-G","article-title":"Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils.","volume":"28","author":"Elsner","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"2026030700011353400_B17","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.163.3.1602","article-title":"A novel human CC chemokine, eotaxin-3, which is expressed in IL-4- stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.","volume":"163","author":"Shinkai","year":"1999","journal-title":"J. Immunol."},{"key":"2026030700011353400_B18","doi-asserted-by":"crossref","first-page":"27975","DOI":"10.1074\/jbc.274.39.27975","article-title":"Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3.","volume":"274","author":"Kitaura","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2026030700011353400_B19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1432-1033.1997.00507.x","article-title":"Characterisation of macrophage inflammatory protein-5\/human CC cytokine- 2, a member of the macrophage-inflammatory-protein family of chemokines.","volume":"248","author":"Coulin","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"2026030700011353400_B20","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.4049\/jimmunol.165.6.2943","article-title":"A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues.","volume":"165","author":"Pan","year":"2000","journal-title":"J. Immunol."},{"key":"2026030700011353400_B21","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.4049\/jimmunol.165.12.7224","article-title":"Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling.","volume":"165","author":"Heinemann","year":"2000","journal-title":"J. Immunol."},{"key":"2026030700011353400_B22","doi-asserted-by":"crossref","first-page":"12959","DOI":"10.1021\/bi990711d","article-title":"Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.","volume":"38","author":"Kuschert","year":"1999","journal-title":"Biochemistry"},{"key":"2026030700011353400_B23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-6147(99)01308-5","article-title":"Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning.","volume":"20","author":"Mennicken","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"2026030700011353400_B24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1084\/jem.185.4.785","article-title":"Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia.","volume":"185","author":"Rothenberg","year":"1997","journal-title":"J. Exp. Med."},{"key":"2026030700011353400_B25","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1164\/ajrccm.163.7.9812044","article-title":"Eotaxin expression after segmental allergen challenge in subjects with atopic asthma.","volume":"163","author":"Lilly","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026030700011353400_B26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2249.1998.00688.x","article-title":"Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation.","volume":"114","author":"Brown","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"2026030700011353400_B27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1165\/ajrcmb.24.6.4301","article-title":"Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge.","volume":"24","author":"Berkman","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2026030700011353400_B28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.188.1.157","article-title":"The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness.","volume":"188","author":"Gonzalo","year":"1998","journal-title":"J. Exp. Med."},{"key":"2026030700011353400_B29","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.4049\/jimmunol.163.7.3976","article-title":"C\u2013C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C- C chemokines (monocyte chemoattractant protein-3 and RANTES).","volume":"163","author":"Ying","year":"1999","journal-title":"J. Immunol."},{"key":"2026030700011353400_B30","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.95.11.6273","article-title":"Eotaxin is required for the baseline level of tissue eosinophils.","volume":"95","author":"Matthews","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026030700011353400_B31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1165\/ajrcmb.22.5.3710","article-title":"Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide.","volume":"22","author":"Tulic","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2026030700011353400_B32","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S0140-6736(00)02239-X","article-title":"Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma.","volume":"355","author":"Gereda","year":"2000","journal-title":"Lancet"},{"key":"2026030700011353400_B33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1164\/ajrccm.163.2.ed2000a","article-title":"Does inhalation of endotoxin cause asthma?","volume":"163","author":"Schwartz","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/25\/6\/673\/67172029\/ajrcmb_25_6_673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/25\/6\/673\/67172029\/ajrcmb_25_6_673.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:13:19Z","timestamp":1772860399000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/25\/6\/673\/8501912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,1]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2001,12,1]]},"published-print":{"date-parts":[[2001,12,1]]}},"URL":"https:\/\/doi.org\/10.1165\/ajrcmb.25.6.f222","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2001,12]]},"published":{"date-parts":[[2001,12,1]]}}}